PLIANT THERAPEUTICS, INC. Operating Lease, Payments
PLIANT THERAPEUTICS, INC. (PLRX) reported Operating Lease, Payments of $5.56 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-03-11
- PLIANT THERAPEUTICS, INC. operating lease, payments for the quarter ending 2023-12-31 was $1.25M, a 64.60% increase year-over-year.
- PLIANT THERAPEUTICS, INC. operating lease, payments for the quarter ending 2023-03-31 was $800.00K, a 33.33% increase year-over-year.
- PLIANT THERAPEUTICS, INC. operating lease, payments for the quarter ending 2022-12-31 was $757.00K, a 51.40% increase year-over-year.
- PLIANT THERAPEUTICS, INC. operating lease, payments for the quarter ending 2022-09-30 was $700.00K, a 0.00% change year-over-year.
- PLIANT THERAPEUTICS, INC. operating lease, payments for fiscal 2025 was $5.56M, a 18.39% increase from fiscal 2024.
- PLIANT THERAPEUTICS, INC. operating lease, payments for fiscal 2024 was $4.70M, a 22.15% increase from fiscal 2023.
- PLIANT THERAPEUTICS, INC. operating lease, payments for fiscal 2023 was $3.85M, a 44.75% increase from fiscal 2022.
- PLIANT THERAPEUTICS, INC. operating lease, payments for fiscal 2022 was $2.66M, a 10.71% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $5.56M 10-K · filed 2026-03-11 | ||||
| 2024-12-31 | $4.70M 10-K · filed 2026-03-11 | ||||
| 2023-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $3.85M 10-K · filed 2025-03-03 | |||
| 2023-09-30 | $2.60M 10-Q · filed 2023-11-09 | ||||
| 2023-03-31 | $800.00K 10-Q · filed 2023-05-09 | $1.56M derived: sum of 2 quarters · filed 2025-03-03 | $2.26M derived: sum of 3 quarters · filed 2025-03-03 | $2.86M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2022-12-31 | $757.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.46M derived: sum of 2 quarters · filed 2025-03-03 | $2.06M derived: sum of 3 quarters · filed 2025-03-03 | $2.66M 10-K · filed 2025-03-03 | $2.70M 10-K · filed 2023-03-09 |
| 2022-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.30M derived: sum of 2 quarters · filed 2023-11-09 | $1.90M 10-Q · filed 2023-11-09 | $2.40M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.20M 10-Q · filed 2022-08-08 | $1.70M derived: sum of 3 quarters · filed 2024-02-27 | $2.40M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $600.00K 10-Q · filed 2023-05-09 | $1.10M derived: sum of 2 quarters · filed 2024-02-27 | $1.80M derived: sum of 3 quarters · filed 2024-02-27 | $2.40M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.20M derived: sum of 2 quarters · filed 2024-02-27 | $1.80M derived: sum of 3 quarters · filed 2024-02-27 | $2.40M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.30M derived: sum of 2 quarters · filed 2022-11-08 | $1.90M 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.20M 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | $600.00K 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |